| DAIC

October 11, 2023 — Realizing a vision to deliver the best care to patients close to where they live in northern Ohio, GE HealthCare and University Hospitals (UH) announced a 10-year strategic collaboration to bring GE HealthCare technologies to UH across its radiology practice and UH Harrington Heart & Vascular Institute, providing contemporary equipment and

Read more about GE HealthCare and University Hospitals Enter 10-Year Strategic Collaboration to Contemporize Its Imaging Fleet and Implement Enterprise Digital Solutions to Help Improve Patient Care and Optimize Processes

October 11, 2023 — A newly-issued American Heart Association presidential advisory identifies the strong connections among cardiovascular disease (CVD), kidney disease, Type 2 diabetes and obesity, and suggests redefining CVD risk, prevention and management.

Read more about American Heart Association Presidential Advisory defines cardiovascular-kidney-metabolic (CKM) syndrome for first time

October 11, 2023 — To gain the latest insight into genetic research for the treatment of hypertrophic cardiomyopathy, DAIC's Managing Editor conducted an in-depth interview with

Read more about “One on One” with Christine Seidman, MD, FACC, on Hypertrophic Cardiomyopathy
Log in or register to post comments

October 10, 2023 — Axon Therapies, a private company focused on addressing a root cause of heart failure, announced 6-month results of the REBALAN

Read more about Late-Breaking Data Confirms Safety of Axon Therapies' Innovative Heart Failure Procedure and Identifies Patients Most Likely to Benefit from SAVM Therapy

October 10, 2023 — Hawthorne Effect, a complete clinical trials solution, announced interi

Read more about Hawthorne Effect Announces Monumental Diversity in Patient Recruitment Data for Valvular Heart Disease Study

October 10, 2023 — Elixir Medical, a developer of innovative cardiovascular technologies, announced it will present primary endpoint and 6-month data from its DESyne BDS Plus Randomized Clinical Trial (RCT), a prospec

Read more about Elixir Medical To Present Randomized Clinical Dataset Featuring World’s First Triple Drug-Eluting Coronary Implant Eluting Two Anticoagulants and Sirolimus at TCT 2023

October 10, 2023 — The recipients of two prestigious awards — the Career Achievement Award and the TCT Geoffrey O. Hartzler Master Operator Award — have been announced by the Cardiovascular Research Foundation (CRF) ahead of its annual scientific symposium, the Transcatheter Cardiovascular Therapeutics (TCT) conference.

Read more about Cardiovascular Research Foundation Announces TCT 2023 Award Winners

The global incidence of non-communicable diseases (NCDs) is currently around 40 million cases a year. Of that total, cardiovascular disease amounts to 18 million cases, with approximately 6.5 million being strokes. At 9.3 million cases per year, cancer is only slightly more prevalent.

Read more about Philips in Partnership with the World Stroke Organization: Putting Stroke on the Global Agenda
Log in or register to post comments

October 9, 2023 — The vast majority of people who have a minimally invasive heart valve replacement procedure do not participate in recommended cardiac rehabilitation, a Michigan Medicine-led study finds.

Read more about TAVR: Less Than One-third of Patients Enter Cardiac Rehab After Heart Procedure

October 9, 2023 — Rejuvenate Bio announced new preclinical efficacy data for RJB-0402, a gene therapy targeting key disease-mediating pathways.

Read more about Rejuvenate Bio Announces Preclinical Data for Gene Therapy Candidate RJB-0402 for the Treatment of Arrhythmogenic Cardiomyopathy

Subscribe to

If you enjoy this content, please share it with a colleague

If you enjoy this content, please share it with a colleague